sulfinpyrazone and propranolol
sulfinpyrazone has been researched along with propranolol in 18 studies
Research
Studies (18)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (44.44) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 5 (27.78) | 29.6817 |
2010's | 4 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Mustard, JF; Packham, MA | 1 |
Prozan, GB | 1 |
Mehta, J; Mehta, P | 1 |
Weiss, HJ | 1 |
Schröder, R | 1 |
Hashimoto, H; Ogawa, K | 1 |
DeMets, DL; Friedman, LM; Furberg, C; May, GS; Passamani, E | 1 |
Mehta, JL | 1 |
Davis, JW; Hassanein, KM; Lewis, HD | 1 |
Reviews
4 review(s) available for sulfinpyrazone and propranolol
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Phenprocoumon; Platelet Aggregation; Practolol; Propranolol; Recurrence; Sex Factors; Sulfinpyrazone; Time Factors | 1981 |
The randomized clinical trial: bias in analysis.
Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Humans; Myocardial Infarction; Patient Compliance; Placebos; Propranolol; Random Allocation; Sulfinpyrazone | 1981 |
Trials
2 trial(s) available for sulfinpyrazone and propranolol
Article | Year |
---|---|
The randomized clinical trial: bias in analysis.
Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Humans; Myocardial Infarction; Patient Compliance; Placebos; Propranolol; Random Allocation; Sulfinpyrazone | 1981 |
The effect of sulfinpyrazone on treadmill exercise-induced angina pectoris.
Topics: Angina Pectoris; Double-Blind Method; Exercise Test; Exercise Tolerance; Humans; Male; Middle Aged; Platelet Aggregation; Propranolol; Sulfinpyrazone | 1993 |
Other Studies
13 other study(ies) available for sulfinpyrazone and propranolol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
More on coronary bypass surgery--III.
Topics: Coronary Artery Bypass; Coronary Disease; Humans; Propranolol; Prospective Studies; Sulfinpyrazone; United States; United States Department of Veterans Affairs | 1979 |
Status of antiplatelet drugs in coronary heart disease.
Topics: Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Male; Models, Biological; Platelet Aggregation; Propranolol; Sulfinpyrazone | 1979 |
Antiplatelet therapy (first of two parts).
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Clofibrate; Dextrans; Dipyridamole; Heparin; Humans; Platelet Adhesiveness; Platelet Aggregation; Propranolol; Rabbits; Sulfinpyrazone; Thrombosis | 1978 |
Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis.
Topics: Animals; Aspirin; Body Weight; Creatine Kinase; Cyclic AMP; Heart; Isoproterenol; Male; Myocardial Infarction; Myocardium; Necrosis; Organ Size; Propranolol; Prostaglandins; Rats; Rats, Inbred Strains; Sulfinpyrazone | 1981 |
Platelets and coronary heart disease: therapy update.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Hemostasis; Humans; Propranolol; Prostaglandin Antagonists; Risk; Sulfinpyrazone; Thromboxane A2 | 1982 |